Get started
Author

Andrea‐Hermina Györfi

Observed names: A. H. Györfi, A.-H. Györfi, A.H. Györfi, Andrea Hermina Györfi, Andrea-Hermina Györfi, Györfi, Andrea-Hermina, Györfi, Andrea-Hermina, Györfi, Andrea-Hermina; https://orcid.org/0000-0002-4960-3369, Hermina Györfi
Observed institutions: University of Copenhagen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Aarhus University, Aarhus University Hospital, Hospital Son Llatzer, Universitätsklinikum Erlangen, Düsseldorf University Hospital, Fraunhofer Institute for Translational Medicine and Pharmacology, Nordic Bioscience (Denmark), Heinrich Heine University Düsseldorf
ORCID: 0000-0002-4960-3369
Observed ORCID: 0000-0002-4960-3369
OpenAlex ID: A5077575970
Shared and distinct mechanisms of fibrosis
2019 · Jörg H. W. Distler, Andrea-Hermina Györfi, et al. · Nature Reviews Rheumatology · 640
Targeting TGF-β signaling for the treatment of fibrosis
2018 · Andrea Hermina Györfi, Alexandru-Emil Matei, et al. · Matrix Biology · 274
Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
2023 · Christina Bergmann, Fabian Müller, et al. · Annals of the Rheumatic Diseases · 220
PDF
68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study
2021 · Christina Bergmann, Jörg H W Distler, et al. · The Lancet Rheumatology · 152
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis
2018 · Ariella Zehender, Jingang Huang, et al. · Nature Communications · 127
PDF
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series
2024 · Janina Auth, Fabian Müller, et al. · The Lancet Rheumatology · 124
TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy
2021 · Ariella Zehender, Yi-Nan Li, et al. · Nature Communications · 109
PDF
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study
2025 · Melanie Hagen, Fabian Müller, et al. · The Lancet Rheumatology · 94
Rapid single-cell physical phenotyping of mechanically dissociated tissue biopsies
2023 · Despina Soteriou, Markéta Kubánková, et al. · Nature Biomedical Engineering · 65
PDF
Assessment of myocardial fibrosis in patients with systemic sclerosis using [68Ga]Ga-FAPI-04-PET-CT
2022 · Christoph Treutlein, Jörg H. W. Distler, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 58
PDF
Apolipoprotein E controls Dectin-1-dependent development of monocyte-derived alveolar macrophages upon pulmonary β-glucan-induced inflammatory adaptation
2024 · H. Theobald, D. A. Bejarano, et al. · Nature Immunology · 52
PDF
Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation
2021 · Andrea-Hermina Györfi, Alexandru-Emil Matei, et al. · The Journal of Experimental Medicine · 51
PDF
Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulators
2018 · Alexandru-Emil Matei, Christian Beyer, et al. · Annals of the Rheumatic Diseases · 47
Impaired Mitochondrial Transcription Factor A Expression Promotes Mitochondrial Damage to Drive Fibroblast Activation and Fibrosis in Systemic Sclerosis
2021 · Xiang Zhou, Thuong Trinh‐Minh, et al. · Arthritis & Rheumatology · 45
Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics
2024 · Aleix Rius Rigau, Yi-Nan Li, et al. · Circulation Research · 44
Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs
2019 · Alexandru-Emil Matei, Chih-Wei Chen, et al. · Annals of the Rheumatic Diseases · 43
Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153
2022 · Yi-Nan Li, Chih-Wei Chen, et al. · Bone Research · 39
PDF
PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis
2020 · Yun Zhang, Lichong Shen, et al. · Annals of the Rheumatic Diseases · 39
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis
2024 · Caitríona Grönberg, Sara Rattik, et al. · Annals of the Rheumatic Diseases · 37
PDF
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases
2026 · Christina Düsing, Andrea-Hermina Györfi, et al. · Nature Medicine · 32
PDF
Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort
2025 · Andrea‐Hermina Györfi, Tim Filla, et al. · Journal of the American Heart Association · 29
Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis
2024 · Minrui Liang, Nicholas Dickel, et al. · Science Translational Medicine · 29
Effect of Anti‐S100A4 Monoclonal Antibody Treatment on Experimental Skin Fibrosis and Systemic Sclerosis–Specific Transcriptional Signatures in Human Skin
2023 · Thuong Trinh‐Minh, Andrea‐Hermina Györfi, et al. · Arthritis & Rheumatology · 24
Performance of serum biomarkers reflective of different pathogenic processes in systemic sclerosis-associated interstitial lung disease
2023 · Andrea-Hermina Györfi, Tim Filla, et al. · Lara D. Veeken · 22
Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis
2020 · Andrea Hermina Györfi, Markus Kopp, et al. · Annals of the Rheumatic Diseases · 19
Works count: 94
Citation count: 2,540
H-index: 23
I10-index: 29
Year
Topic
Type